Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (101-110 of 517) with videos related to

Pageof 52
Sort By:
The Oncologist|August 13, 2011
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancerKate Webber, Kelly Mok, Barbara Bennett, et al.
Public Health Research & Practice|May 4, 2021
Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practiceJane Taggart, Melvin Chin, Winston Liauw, et al.
Journal of Surgical Oncology|January 13, 2019
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature reviewFrancesco Sclafani, Gina Hesselberg, Stephen R Thompson, et al.
Cancer Management and Research|June 19, 2018
Performance status dynamics during treatment with <i>nab</i>-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancerE Gabriela Chiorean, Daniel Von Hoff, Yin Wan, et al.
Journal of the Peripheral Nervous System : JPNS|March 30, 2023
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy-induced peripheral neuropathyDaniel White, Munawwar Abdulla, Susanna B Park, et al.
Journal of Cancer Survivorship : Research and Practice|June 8, 2019
Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk testJ Matt McCrary, David Goldstein, David Wyld, et al.
British Journal of Cancer|July 29, 2020
Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasisZhihong Xu, Srinivasa Pothula, David Goldstein, et al.
Hematological Oncology|December 25, 2019
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trialsTiffany Li, Hannah C Timmins, Tracy King, et al.
Journal of Cancer Survivorship : Research and Practice|January 13, 2021
Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic reviewHannah C Timmins, David Mizrahi, Tiffany Li, et al.
Plos Computational Biology|July 25, 2009
Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitorsAndrew J Olaharski, Nina Gonzaludo, Hans Bitter, et al.
Pageof 52

Showing results (101-110 of 517) with videos related to

Sort By:
Pageof 52
The Oncologist|August 13, 2011
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancerKate Webber, Kelly Mok, Barbara Bennett, et al.
Public Health Research & Practice|May 4, 2021
Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practiceJane Taggart, Melvin Chin, Winston Liauw, et al.
Journal of Surgical Oncology|January 13, 2019
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature reviewFrancesco Sclafani, Gina Hesselberg, Stephen R Thompson, et al.
Cancer Management and Research|June 19, 2018
Performance status dynamics during treatment with <i>nab</i>-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancerE Gabriela Chiorean, Daniel Von Hoff, Yin Wan, et al.
Journal of the Peripheral Nervous System : JPNS|March 30, 2023
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy-induced peripheral neuropathyDaniel White, Munawwar Abdulla, Susanna B Park, et al.
Journal of Cancer Survivorship : Research and Practice|June 8, 2019
Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk testJ Matt McCrary, David Goldstein, David Wyld, et al.
British Journal of Cancer|July 29, 2020
Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasisZhihong Xu, Srinivasa Pothula, David Goldstein, et al.
Hematological Oncology|December 25, 2019
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trialsTiffany Li, Hannah C Timmins, Tracy King, et al.
Journal of Cancer Survivorship : Research and Practice|January 13, 2021
Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic reviewHannah C Timmins, David Mizrahi, Tiffany Li, et al.
Plos Computational Biology|July 25, 2009
Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitorsAndrew J Olaharski, Nina Gonzaludo, Hans Bitter, et al.
Pageof 52